Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis
- 1 August 1997
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 49 (2) , 378-385
- https://doi.org/10.1212/wnl.49.2.378
Abstract
The objective of this study was to determine whether sequence variation in the tumor necrosis factor alpha (TNFα) gene is associated with MS course and severity in Olmsted County, MN. The severity and temporal course of MS are heterogeneous. Genetic factors may play a role in determining the course of MS. TNFα expression is temporally associated with exacerbations of MS and is increased in individuals with progressive disease. The entire TNFα gene was amplified by polymerase chain reaction in 78 MS patients and in 39 patients with schizophrenia. Denaturation fingerprinting, a modification of direct sequencing that detects virtually all genetic polymorphisms, was performed for four regions spanning the functionally significant portions of the gene, including the promoter region. Polymorphisms were confirmed by complete sequencing. The severity and temporal course of MS were compared in those with wild-type versus variant alleles. Four sequence changes were detected, three of which occurred in MS patients. None occurred in a protein-encoding sequence. Neither of the two most common sequence variants were associated with disease severity or temporal course. Genetic variation of the TNFα gene is not associated with variation in the course or long-term outcome of MS in this population-based sample.Keywords
This publication has 14 references indexed in Scilit:
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Dramatically Different Phenotypes in Mouse Models of Human Tay-Sachs and Sandhoff DiseasesHuman Molecular Genetics, 1996
- Corticotropin-releasing hormone is involved in conditioned stimulus-induced reduction of natural killer cell activity but not in conditioned alterations in cytokine production or proliferation responsesJournal of Neuroimmunology, 1995
- Choices Following Antigen Entry: Antibody Formation or Immunologic Tolerance?Annual Review of Immunology, 1995
- The role of genetic factors in multiple sclerosis susceptibilityJournal of Neuroimmunology, 1994
- Radioastronomers hope for world observatoryNature, 1994
- Regulation of MHC gene expressionCurrent Opinion in Immunology, 1993
- Delineation of genetic predisposition to multifactorial disease: A general approach on the threshold of feasibilityGenomics, 1992
- The Lewy body variant of Alzheimer's diseaseNeurology, 1990
- Axonal transport in neurological diseaseAnnals of Neurology, 1988